Randomized, double-blind, placebo-controlled, clinical study on the effect of Diabetinol^® on glycemic control of subjects with impaired fasting glucose

References

• FonsecaVAKirkmanMSDarsowTRatnerREThe American Diabetes Association diabetes research perspectiveDiabetes Care2012351380 138722619289
   PubMed Web of Science ®Google Scholar
• RodbardHWJellingerPSDavidsonJAStatement by an American Association of Clinical Endocrinologists/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic controlEndocr Pract200915540 55919858063
   PubMed Web of Science ®Google Scholar
• ChangHYWallisMTiralongoEUse of complementary and alternative medicine among people with type 2 diabetes in Taiwan: a cross-sectional surveyEvid Based Complement Alternat Med20112011 Epub9 82010
   Web of Science ®Google Scholar
• GoldfineABAssessing the cardiovascular safety of diabetes therapiesN Engl J Med20083591092 109518784098
   PubMed Web of Science ®Google Scholar
• NissenSEWolskiKEffect of rosiglitazone on the risk of myocardial infarction and death from cardiovascular causesN Engl J Med20073562457 247117517853
   PubMed Web of Science ®Google Scholar
• GoldnerMGKnatterudGLProutTEEffects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP resultsJAMA19712181400 14104941698
   PubMed Web of Science ®Google Scholar
• GersteinHCMillerMEByingtonRPEffects of intensive glucose lowering in type 2 diabetesN Engl J Med20083582545 255918539917
   PubMed Web of Science ®Google Scholar
• PatelAMacMahonSChalmersJIntensive blood glucose control and vascular outcomes in patients with type 2 diabetesN Engl J Med20083582560 257218539916
   PubMed Web of Science ®Google Scholar
• American Diabetes AssociationStandards of medical care in diabetes – 2012Diabetes Care201235Suppl 1S11 S6322187469
   PubMed Web of Science ®Google Scholar
• MollerDENew drug targets for type 2 diabetes and the metabolic syndromeNature2001414821 82711742415
   PubMed Web of Science ®Google Scholar
• MannucciEOgnibeneASposatoIFasting plasma glucose and glycated haemoglobin in the screening of diabetes and impaired glucose toleranceActa Diabetol200340181 18614740278
   PubMed Web of Science ®Google Scholar
• MazokopakisEEStarakisIKRecommendations for diagnosis and management of metformin-induced vitamin B12 (Cbl) deficiencyDiabetes Res Clin Pract201297359 36722770998
   PubMed Web of Science ®Google Scholar
• de JagerJKooyALehertPLong term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trialBMJ2010340c218120488910
   PubMed Web of Science ®Google Scholar
• BlondeLState of diabetes care in the United StatesAm J Manag Care200713Suppl 2S36 S4017417931
   PubMed Web of Science ®Google Scholar
• AndersonRAPolanskyMMTea enhances insulin activityJ Agric Food Chem2002507182 718612428980
   PubMed Web of Science ®Google Scholar
• SaydahSHFradkinJCowieCCPoor control of risk factors for vascular disease among adults with previously diagnosed diabetesJAMA2004291335 34214734596
   PubMed Web of Science ®Google Scholar
• MechanickJIBrettEMChausmerABDickeyRAWallachSAmerican Association of Clinical Endocrinologists medical guidelines for the clinical use of dietary supplements and nutraceuticalsEndocr Pract20039417 47014583426
   PubMedGoogle Scholar
• van DamRMFeskensEJCoffee consumption and risk of type 2 diabetes mellitusLancet20023601477 147812433517
   PubMed Web of Science ®Google Scholar
• VuksanVSievenpiperJLKooVYAmerican ginseng (Panax quinquefolius L) reduces postprandial glycemia in nondiabetic subjects and subjects with type 2 diabetes mellitusArch Intern Med20001601009 101310761967
   PubMed Web of Science ®Google Scholar
• VuksanVSievenpiperJLWongJAmerican ginseng (Panax quinquefolius L.) attenuates postprandial glycemia in a time-dependent but not dose-dependent manner in healthy individualsAm J Clin Nutr200173753 75811273850
   PubMed Web of Science ®Google Scholar
• DaviGSantilliFPatronoCNutraceuticals in diabetes and metabolic syndromeCardiovasc Ther201028216 22620633024
   PubMed Web of Science ®Google Scholar
• NahasRMoherMComplementary and alternative medicine for the treatment of type 2 diabetesCan Fam Physician200955591 59619509199
   PubMed Web of Science ®Google Scholar
• PandeyATripathiPPandeyRSrivatavaRGoswamiSAlternative therapies useful in the management of diabetes: a systematic reviewJ Pharm Bioallied Sci20113504 51222219583
   PubMedGoogle Scholar
• AssiniJMMulvihillEEHuffMWCitrus flavonoids and lipid metabolismCurr Opin Lipidol20132434 4023254473
   PubMed Web of Science ®Google Scholar
• SharmaAKBhartiSOjhaSUp-regulation of PPARgamma, heat shock protein-27 and -72 by naringin attenuates insulin resistance, beta-cell dysfunction, hepatic steatosis and kidney damage in a rat model of type 2 diabetesBr J Nutr20111061713 172321736771
   PubMed Web of Science ®Google Scholar
• AssiniJMMulvihillEESutherlandBGNaringenin prevents cholesterol-induced systemic inflammation, metabolic dysregulation, and atherosclerosis in Ldlr(−)/(−) miceJ Lipid Res201354711 72423269394
   PubMed Web of Science ®Google Scholar
• AlamMAKauterKBrownLNaringin improves diet-induced cardiovascular dysfunction and obesity in high carbohydrate, high fat diet-fed ratsNutrients20135637 65023446977
   PubMed Web of Science ®Google Scholar
• ParkHJJungUJChoSJJungHKShimSChoiMSCitrus unshiu peel extract ameliorates hyperglycemia and hepatic steatosis by altering inflammation and hepatic glucose- and lipid-regulating enzymes in db/db miceJ Nutr Biochem201324419 42722694954
   PubMed Web of Science ®Google Scholar
• ShinEJHurHJSungMJEthanol extract of the Prunus mume fruits stimulates glucose uptake by regulating PPAR-gamma in C2C12 myotubes and ameliorates glucose intolerance and fat accumulation in mice fed a high-fat dietFood Chem20131414115 412123993593
   PubMed Web of Science ®Google Scholar
• McCulloughMLPetersonJJPatelRJacquesPFShahRDwyerJTFlavonoid intake and cardiovascular disease mortality in a prospective cohort of US adultsAm J Clin Nutr201295454 46422218162
   PubMed Web of Science ®Google Scholar
• JungUJKimHJLeeJSNaringin supplementation lowers plasma lipids and enhances erythrocyte antioxidant enzyme activities in hypercholesterolemic subjectsClin Nutr200322561 56814613759
   PubMed Web of Science ®Google Scholar
• DemontyILinYZebregsYEThe citrus flavonoids hesperidin and naringin do not affect serum cholesterol in moderately hypercholesterolemic men and womenJ Nutr20101401615 162020660284
   PubMed Web of Science ®Google Scholar
• KuhadAChopraKTocotrienol attenuates oxidative-nitrosative stress and inflammatory cascade in experimental model of diabetic neuropathyNeuropharmacology200957456 46219555701
   PubMed Web of Science ®Google Scholar
• WongWYPoudyalHWardLCBrownLTocotrienols reverse cardiovascular, metabolic and liver changes in high carbohydrate, high fat diet-fed ratsNutrients201241527 154123201770
   PubMed Web of Science ®Google Scholar
• OnoEInoueJHashidumeTShimizuMSatoRAnti-obesity and anti-hyperglycemic effects of the dietary citrus limonoid nomilin in mice fed a high-fat dietBiochem Biophys Res Commun2011410677 68121693102
   PubMed Web of Science ®Google Scholar
• JudyWStogsdillWJudyDEfficacy of Diabetinol™ on glycemic control in insulin resistant hamsters and subjects with impaired fasting glucose – a pilot studyJ Funct Foods20102171 178
   Web of Science ®Google Scholar
• GomyoMSakaneNKamaeIEffects of sex, age and BMI on screening tests for impaired glucose toleranceDiabetes Res Clin Pract200464129 13615063606
   PubMed Web of Science ®Google Scholar
• BasuRDallaMCCampioniMEffects of age and sex on postprandial glucose metabolism: differences in glucose turnover, insulin secretion, insulin action, and hepatic insulin extractionDiabetes2006552001 201416804069
   PubMed Web of Science ®Google Scholar
• KirkmanMSBriscoeVJClarkNDiabetes in older adultsDiabetes Care2012352650 266423100048
   PubMed Web of Science ®Google Scholar
• GiuglianoDCerielloAEspositoKGlucose metabolism and hyperglycemiaAm J Clin Nutr200887217S 222S18175761
   PubMed Web of Science ®Google Scholar
• AvignonARadauceanuAMonnierLNonfasting plasma glucose is a better marker of diabetic control than fasting plasma glucose in type 2 diabetesDiabetes Care1997201822 18269405900
   PubMed Web of Science ®Google Scholar
• BonoraECalcaterraFLombardiSPlasma glucose levels throughout the day and HbA(1c) interrelationships in type 2 diabetes: implications for treatment and monitoring of metabolic controlDiabetes Care2001242023 202911723077
   PubMed Web of Science ®Google Scholar
• MonnierLLapinskiHColetteCContributions of fasting and postprandial plasma glucose increments to the overall diurnal hyperglycemia of type 2 diabetic patients: variations with increasing levels of HbA(1c)Diabetes Care200326881 88512610053
   PubMed Web of Science ®Google Scholar
• RheeMKZiemerDCKolmPPhillipsLSPostchallenge glucose rises with increasing age even when glucose tolerance is normalDiabet Med2006231174 117917054591
   PubMed Web of Science ®Google Scholar
• CampbellIWComparing the actions of older and newer therapies on body weight: to what extent should these effects guide the selection of antidiabetic therapy?Int J Clin Pract201064791 80120518953
   PubMed Web of Science ®Google Scholar
• GarberAJObesity and type 2 diabetes: which patients are at risk?Diabetes Obes Metab201214399 40822074144
   PubMed Web of Science ®Google Scholar
• GordonDJProbstfieldJLGarrisonRJHigh-density lipoprotein cholesterol and cardiovascular disease. Four prospective American studiesCirculation1989798 152642759
   PubMed Web of Science ®Google Scholar
• KeilUCoronary artery disease: the role of lipids, hypertension and smokingBasic Res Cardiol200095Suppl 1I52 I5811192354
   PubMedGoogle Scholar
• KoellerJTalbertRLModification of high-density lipoprotein cholesterol in the management of cardiovascular riskPharmacotherapy2002221266 127712389877
   PubMed Web of Science ®Google Scholar
• BlumbergJHeaneyRPHuncharekMEvidence-based criteria in the nutritional contextNutr Rev201068478 48420646225
   PubMed Web of Science ®Google Scholar
• HeaneyRPThe nutrient problemNutr Rev201270165 16922364158
   PubMed Web of Science ®Google Scholar
• OndaKHorikeNSuzukiTHiranoTPolymethoxyflavonoids tangeretin and nobiletin increase glucose uptake in murine adipocytesPhytother Res201327312 31622585555
   PubMed Web of Science ®Google Scholar
• MulvihillEEAssiniJMLeeJKNobiletin attenuates VLDL overproduction, dyslipidemia, and atherosclerosis in mice with diet-induced insulin resistanceDiabetes2011601446 145721471511
   PubMed Web of Science ®Google Scholar
• MiyataYTanakaHShimadaARegulation of adipocytokine secretion and adipocyte hypertrophy by polymethoxyflavonoids, nobiletin and tangeretinLife Sci201188613 61821295043
   PubMed Web of Science ®Google Scholar
• LeeYSChaBYSaitoKNobiletin improves hyperglycemia and insulin resistance in obese diabetic ob/ob miceBiochem Pharmacol2010791674 168320144590
   PubMed Web of Science ®Google Scholar